期刊文献+

6项指标在肝纤维化评估中的临床应用 被引量:9

下载PDF
导出
摘要 目的探讨慢性肝炎患者6项指标用于肝纤维化评估的价值。方法185例慢性肝炎患者行常规肝穿刺、组织病理学诊断,用ELISA法检测血清中结缔组织生长因子(CTGF)、血小板衍生生长因子-BB(PDGF-BB)、金属蛋白酶抑制剂-1(TIMP-1)、转化生长因子-β1(TGF-β1),常规检测凝血酶原时间(PT)、门冬氨酸氨基转移酶(AST)和血小板(PLT)及其计算指标APRI(AST/PLT),用ROC曲线评估这些指标在肝纤维化诊断中的价值。结果血清CTGF、PDGF-BB、TIMP-1、TGF-β1、APRI、PT的ROC曲线下面积(AUC)分别为:0.833,0.811,0.669,0.529,0.809,0.625。联合CTGF和APRI可以明显提高诊断的准确性。结论CTGF、PDGF-BB、APRI在肝纤维化评估中有较高的诊断价值,联合这些指标可以提高肝纤维化的诊断性能。
出处 《临床检验杂志》 CAS CSCD 北大核心 2009年第4期280-282,共3页 Chinese Journal of Clinical Laboratory Science
基金 南京市医学重点科技发展项目(No.ZKX0303)
  • 相关文献

参考文献13

  • 1Yoshida H, Shiratori Y, Moriyama M, et al. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotie patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy [ J]. Ann Intern Med, 1999, 131 (3) : 174- 181.
  • 2Poynard T, McHutchison J, Davis GL, et al. Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C [ J ]. Hepatology, 2000, 32 (5) : 1131-1137.
  • 3Gressner O A, Weiskirchen R, Gressner A M. Biomarkers of liver fibrosis : Clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests [ J]. Clin Chim Acta, 2007, 381 (2) :107-113.
  • 4中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14012
  • 5Chun-Tao Wai,Greenson J K, Robert J,et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C [J]. Hepatology, 2003, 38(2) :518-526.
  • 6Afdhal N H, Curry M. Technology evaluation: A critical step in the clinical utilization of novel diagnostic tests for liver fibrosis [ J ]. J Hepatology, 2002, 46 (4) : 543 -545.
  • 7丁宁,李岩.转化生长因子β_1和结缔组织生长因子在肝纤维化中的表达[J].世界华人消化杂志,2006,14(25):2521-2526. 被引量:14
  • 8Peterson M C. Circulating transforming growth factor beta-1 : a partial molecular explanation for associations between hypertension, diabetes, obesity, smoking and human disease involving fibrosis [ J]. Med Sci Monit,2005,11 (7) : RA229-232.
  • 9Duncan MR, Frazier KS, Abramson S, et al. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP [ J ]. FASEB J, 1999, 13 (13) : 1774-1786.
  • 10Paradis V, Dargere D, Vidaud M, et al. Expression of connective tissue growth factor in experimental rat and human liver fibrosis [J]. Hepatology, 1999, 30(4) :968-976.

二级参考文献32

  • 1Kanzler S, Baumann M, Schirmacher P, et al. Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta [ J ]. J Viral Hepatol, 2001,8 ( 6 ) : 430-437.
  • 2Shek F W, Benyon R C. How can transforming growth factor beta be targeted usefully to combat liver fibrosis? [ J ]. Eur J Gastroenterol Hepatol,2004,16(2 ) : 123-126.
  • 3Bradham D M, Igarashi A, Potter R L,et al. Connective tissue growth factor: a cysteine rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early geue product CEF-10[ J]. J Cell Biol,1991,114(6) :1258-1294.
  • 4Gupta S, Clarkson M R, Duggan J, et al. Connective tissue growth factor: potential tole in glomerulosclerosis and tubulointerstitial fibrosis [ J]. Kidney Int,2000,58 (4) : 13892-13899.
  • 5Lau L F, Lain S C. The CCN family of angiogenic regulators : the integrin connection [ J ]. Exp Cell Res, 1999,248 ( 1 ) :44 -57.
  • 6Rachfal A W, Brigstock D R. Connective tissue growth factor ( CTGF/ CCN2) in hepatic fibrosis[ J]. Hepatol Res,2003 ;26( 1 ) : 1-9.
  • 7Gressner A M, Yagmur E, Lahme B, et al. Connective tissue growth factor in serum as a new candidate test for assessment of hepatic fibrosis[J]. Clin Chem,2006,52(9) :1815-1817.
  • 8Hayashi N, Kakimuma T, Soma Y, et al. Connective tissue growth factor is directly related to liver fibrosis [ J ]. Hepatogastroenterology, 2002,49(43) :133-135.
  • 9Wenger C, Ellenrieder V, Alber B, et al. Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells [ J ]. Oncogene, 1999,18 ( 4 ) : 1073-1080.
  • 10Di Mola F F, Friess H, Martignoni M E, et al. Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis [J]. Ann Surg,1999,230( 1 ) :63-71.

共引文献14029

同被引文献102

引证文献9

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部